E-LIB Suche - Ergebnisse für: Sierra Madero, Juan

1

Three-year durable efficacy of dolutegravir plus lamivudine..:

Cahn, Pedro ; Sierra Madero, Juan ; Arribas, José R....
AIDS. 36 (2021) 1 - p. 39-48 , 2021

2

Impact of treatment adherence on efficacy of dolutegravir p..:

Ait-Khaled, Mounir ; Sierra Madero, Juan ; Estrada, Vicente...
HIV Research & Clinical Practice. 23 (2021) 1 - p. 9-14 , 2021

Link: https://doi.org/10.1080/..

3

Maraviroc, as a Switch Option, in HIV-1–infected Individual..:

Pett, Sarah Lilian ; Amin, Janaki ; Horban, Andrejz...
Clinical Infectious Diseases. 63 (2016) 1 - p. 122-132 , 2016

Link: https://doi.org/10.1093/..

4

Changes in lipid levels after 48 weeks of dual versus tripl..:

Cahn, Pedro ; Andrade Villanueva, Jaime ; Arribas, Jose...
Journal of the International AIDS Society. 17 (2014) 4S3 - p. , 2014

Link: https://doi.org/10.7448/..

5

Adjuvant Topical Interferon Alpha 2b for the Treatment of M..:

Arteaga-Rivera, José Y. ; Vigderovich-Cielak, Itamar ; Ramirez-Miranda, Arturo...
Cornea. 42 (2023) 12 - p. 1578-1581 , 2023

Link: https://doi.org/10.1097/..

6

381. HIV Patients with COVID-19 Hospitalized in a Tertiary ..:

Espejo Ortiz, Cristian E ; Serrano Pinto, Yamile G ; Sierra Madero, Juan G..
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S260-S260 , 2020

Link: https://doi.org/10.1093/..

7

Vitamin D, d -dimer, Interferon γ, and sCD14 Levels are Ind..:

Musselwhite, Laura W. ; Andrade, Bruno B. ; Ellenberg, Susan S....
EBioMedicine. 4 (2016) - p. 115-123 , 2016

Link: https://doi.org/10.1016/..

8

Factores psicosociales asociados con el inicio tardío de tr..:

Sierra Madero, Juan G. ; Nogueda-Orozco, María José ; Caro-Vega, Yanink..
Salud Pública de México. 57 (2015) - p. 135 , 2015

Link: https://doi.org/10.21149..

9

Escala de Ansiedad y Depresión Hospitalaria (hads): validac..:

Nogueda Orozco, María José ; Pérez Terán, Brenda ; Barrientos Casarrubias, Vania..
Psicología Iberoamericana. 21 (2013) 2 - p. 29-37 , 2013

Link: https://doi.org/10.48102..

10

Oral secondary syphilis in a patient with human immunodefic..:

Ramirez-Amador, Velia ; Sierra Madero, Juan G. ; Pedraza, Lilly Esquivel...
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 81 (1996) 6 - p. 652-654 , 1996

Link: https://doi.org/10.1016/..

11

Seroepidemiology of SARS-CoV-2 in healthcare personnel work..:

Dávila-Conn, Vanessa ; Soto-Nava, Maribel ; Caro-Vega, Yanink N....
PLOS ONE. 17 (2022) 3 - p. e0264964 , 2022

Link: https://doi.org/10.1371/..

12

Risk factors associated with HCV co-infection amongst MSM a..:

Ramirez-Gonzalez, Luis E. ; Camiro-Zúñiga, Antonio ; Piñeirua- Menendez, Alicia...
Annals of Hepatology. 27 (2022) 6 - p. 100758 , 2022

Link: https://doi.org/10.1016/..

13

EFICÁCIA DURADOURA DE DOLUTEGRAVIR MAIS LAMIVUDINA NO TRATA..:

Porteiro, Norma ; Cahn, Pedro ; Madero, Juan Sierra...
The Brazilian Journal of Infectious Diseases. 26 (2022) - p. 102125 , 2022

Link: https://doi.org/10.1016/..

14

Clinical effects of durability of immunosuppression in viro..:

Caro-Vega, Yanink ; Rebeiro, Peter F. ; Shepherd, Bryan E....
The Lancet Regional Health - Americas. 8 (2022) - p. 100175 , 2022

Link: https://doi.org/10.1016/..

15

Retention in Care, Mortality, Loss-to-Follow-Up, and Viral ..:

Caro-Vega, Yanink ; Alarid-Escudero, Fernando ; Enns, Eva A....
Pathogens. 10 (2021) 12 - p. 1569 , 2021

Link: https://doi.org/10.3390/..